Bogart Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Bogart Wealth's ALNY Position: Q3 2026 in Review
Bogart Wealth reduced its Alnylam Pharmaceuticals (ALNY) stake by 2.2% in Q3 2026, selling an estimated $254 and leaving 45 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #986.
Bogart Wealth first reported a position in ALNY in Q1 2021 and has held it in 23 quarters since. The position peaked at $16K in Q3 2025. 726 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Bogart Wealth held 45 shares of Alnylam Pharmaceuticals worth $11.1K as of Q3 2026.
- Bogart Wealth sold 1 Alnylam Pharmaceuticals share in Q3 2026, an estimated $254.
- Alnylam Pharmaceuticals made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #986 holding.
- Bogart Wealth first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 23 quarters since.
- Bogart Wealth's Alnylam Pharmaceuticals position peaked at $16K in Q3 2025.
- 726 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.